CVS Health Co. (NYSE:CVS) Position Decreased by Teamwork Financial Advisors LLC

Teamwork Financial Advisors LLC reduced its holdings in CVS Health Co. (NYSE:CVSFree Report) by 9.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,190 shares of the pharmacy operator’s stock after selling 1,755 shares during the quarter. Teamwork Financial Advisors LLC’s holdings in CVS Health were worth $1,018,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in CVS. Steph & Co. boosted its stake in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 288 shares in the last quarter. Kapitalo Investimentos Ltda purchased a new position in CVS Health in the 4th quarter worth about $36,000. Crewe Advisors LLC acquired a new stake in CVS Health during the 1st quarter worth about $40,000. Retirement Group LLC lifted its stake in CVS Health by 54.3% during the first quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock valued at $41,000 after buying an additional 182 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the third quarter worth approximately $33,000. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on CVS. Evercore ISI raised their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. Barclays raised CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $63.00 to $82.00 in a research note on Thursday, October 10th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Finally, Truist Financial raised their price target on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $75.26.

Get Our Latest Report on CVS Health

CVS Health Stock Down 2.1 %

CVS Health stock opened at $63.67 on Friday. The firm has a market cap of $79.93 billion, a price-to-earnings ratio of 11.19, a P/E/G ratio of 0.93 and a beta of 0.54. The firm has a fifty day moving average price of $59.73 and a two-hundred day moving average price of $60.75. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVSGet Free Report) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.21 EPS. As a group, analysts forecast that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a $0.665 dividend. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.18%. CVS Health’s dividend payout ratio is currently 46.75%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.